{"filing":{"accession_number":"0001104659-26-075126","cik":"0001643303","ticker":"NNDM","company_name":"Nano Dimension Ltd.","form":"8-K","filing_date":"2026-06-17","report_date":null,"primary_document":"tm2618166d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1643303/000110465926075126/tm2618166d1_8k.htm"},"events":[{"id":11540,"run_id":10136,"accession_number":"0001104659-26-075126","anchor_item_number":"7.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"summary":"The filing discloses a proposed business combination between Nano Dimension Ltd. and Infinite Epigenetics, Inc., with a press release issued on June 16, 2026 providing additional information about the transaction. The disclosure references an anticipated Definitive Agreement, Form S-4 registration statement, and proxy statement/prospectus, all hallmarks of a material M\u0026A transaction requiring shareholder approval. This is a material event that would significantly affect investor assessment of the registrant.","company_name":"Nano Dimension Ltd.","ticker":"NNDM","filing_date":"2026-06-17","submitted_at":null,"items":[{"id":8146,"accession_number":"0001104659-26-075126","item_number":"7.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"The filing discloses a proposed business combination between Nano Dimension Ltd. and Infinite Epigenetics, Inc., with a press release issued on June 16, 2026 providing additional information about the transaction. The disclosure references an anticipated Definitive Agreement, Form S-4 registration statement, and proxy statement/prospectus, all hallmarks of a material M\u0026A transaction requiring shareholder approval. This is a material event that would significantly affect investor assessment of the registrant.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:08:52.420822+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8146,"accession_number":"0001104659-26-075126","item_number":"7.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"The filing discloses a proposed business combination between Nano Dimension Ltd. and Infinite Epigenetics, Inc., with a press release issued on June 16, 2026 providing additional information about the transaction. The disclosure references an anticipated Definitive Agreement, Form S-4 registration statement, and proxy statement/prospectus, all hallmarks of a material M\u0026A transaction requiring shareholder approval. This is a material event that would significantly affect investor assessment of the registrant.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:08:52.420822+00:00","company_name":"Nano Dimension Ltd.","ticker":"NNDM","filing_date":"2026-06-17"}]}